Such interaction may imply a hidden mechanism in AD’s pathogenesis that increases KMO production and thus decreases levels of neuroprotective kynurenine metabolite and enhances AD symptoms, which explains AD’s connection to acute viral myocarditis. The gene discussed is KMO; the disease is Alzheimer disease.